Transcatheter interatrial shunt device provides sustained clinical benefit at one year in patients with preserved or mildly reduced ejection fraction: the REDUCE LAP heart failure trial - Kaye, David M.; Raake, Philip (Circulation, 2016)
Gesehen am 15.08.2017